Skip to main content
Smart Investors Daily
Aclarion, Inc. logo

NASDAQ · ACONW

Aclarion, Inc.

Healthcare · Medical - Healthcare Information Services

$0.03

Up+$0.00 (+17.65%)

Updated Nov 5, 2026, 1:36 PM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
19.95K
P/E ratio
-0.22
Dividend yield
0.00%
52-week range
$0.02 – $0.20
Volume
4.09K
Avg. volume
17.8K

Price performance · ACONW

ACONW price history

1M range · 10 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

ACONW closed at $0.03 after 10 trading sessions, up 27.01% for the selected period.

Last close
$0.03
Period change
+27.01%
Period low
$0.02
Period high
$0.03
Daily close
View OHLC price history
ACONW OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$0.0268$0.0268$0.0268$0.02684.09K
Nov 2, 2026$0.024$0.0243$0.021$0.02218K
Oct 30, 2026$0.021$0.0247$0.021$0.02474.69K
Oct 29, 2026$0.0247$0.0247$0.0247$0.0247100
Oct 22, 2026$0.026$0.026$0.021$0.0258103.39K
Oct 21, 2026$0.0211$0.0211$0.021$0.0217.93K
Oct 20, 2026$0.021$0.0274$0.021$0.02449.7K
Oct 15, 2026$0.025$0.0279$0.0214$0.02753.32K
Oct 14, 2026$0.0298$0.0298$0.0279$0.027911.41K
Oct 8, 2026$0.0211$0.0211$0.0211$0.0211498

Latest ACONW news

The latest Smart Investors Daily articles mentioning ACONW.

ACONW research

Overview

Company profile and research snapshot.

Company profile

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.